Page last updated: 2024-08-23

lovastatin and Muscle Disorders

lovastatin has been researched along with Muscle Disorders in 55 studies

Research

Studies (55)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (10.91)	18.7374
1990's	29 (52.73)	18.2507
2000's	16 (29.09)	29.6817
2010's	3 (5.45)	24.3611
2020's	1 (1.82)	2.80

Authors

Authors	Studies
Hoffmann, TJ; Iribarren, C; Krauss, RM; Lu, B; Medina, MW; Oni-Orisan, A; Risch, N; Seraydarian, M; Sun, L	1
Christopher-Stine, L; Isackson, PJ; Kitzmiller, JP; Luzum, JA; Ma, C; Nguyen, LM; Ochs-Balcom, HM; Peltier, W; Tarnopolsky, M; Vladutiu, GD; Weisman, M; Wortmann, RL	1
Aschmann, HE; Kaufmann, M; Puhan, MA; Yebyo, HG	1
Abdul Rahman, H; Ahmad, Z; C Thambiah, S; Chew, BH; Hasan, S; Meor Anuar Shuhaili, MFR; Samsudin, IN; Stanslas, J	1
Dimauro, S; Lai, PS; Pang, AY; Tay, SK; Yap, HK	1
Abel, T; Fehér, J	1
Bannykh, S; England, JD; Gray, NL; Haas, RH; Hathaway, S; Kimura, BJ; Phillips, PS; Vladutiu, GD	1
Sinzinger, H	1
Gotto, AM	1
Müller, T	1
Olive, KE; Smith, DJ	1
Rubenfire, M	1
Cartwright, MS; Donofrio, PD; Jeffery, DR; Nuss, GR	1
Cortese, C; Lewis, B; Marenah, CB; Mitchell, WD; Reynolds, EH; Shakir, R	1
Galiana, J; Marchán, E; Montés, I; Pato, S	1
Ahmad, S	1
Tobert, JA	3
Bradford, RH; Chremos, AN; Dujovne, CA; Franklin, FA; Grillo, RB; Higgins, J; Langendorfer, A; Nash, DT; Pool, JL; Shear, CL	1
al-Jubouri, MA; Briston, PG; Chinn, RH; Sinclair, D; Young, RM	1
Day, AP; Stansbie, D	1
Fukami, M; Fukushige, J; Kogure, Y; Maeda, N; Ogawa, T; Shimada, Y; Tsujita, Y	1
Engel, AG; Lindal, S; Waclawik, AJ	1
Bradford, RH; Chremos, AN; Downton, M; Langendörfer, A; Mantell, G; Nash, DT; Shear, CL; Stinnett, S	1
Rosenson, RS	1
Ichikawa, M; Matsuyama, K; Nakai, A; Nishikata, M; Uchida, T	1
Isley, W; Rajeshawari, M; Tal, A	1
Dabroś, W; Dudek, D; Stachura, J; Wicher-Muniak, E; Zmudka, K	1
Chehne, F; Lupattelli, G; Sinzinger, H	1
Lupattelli, G; Palumbo, B; Sinzinger, H	1
Bottorff, M; Worz, CR	1
Hodel, C	1
Bellosta, S; Corsini, A; Paoletti, R	1
Arimura, K; Higuchi, I; Kuriyama, M; Nagado, T; Nagata, K; Nakagawa, M; Nakahara, K; Osame, M; Yoshidome, H	1
Chucrallah, A; De Girolami, U; Federman, M; Freeman, R	1
Eydelloth, RS; Germershausen, JI; Grossman, SJ; MacDonald, JS; Schwartz, MS; Smith, PF; Stubbs, RJ	1
Bradford, RH; Chremos, AN; Downton, M; Dujovne, CA; Franklin, FA; Higgins, J; Nash, DT; Pool, JL; Schnaper, H; Shear, CL	1
Colley, C; Lucas, LM; Magarian, GJ	1
Eydelloth, RS; Germershausen, JI; Grossman, SJ; Kari, PH; MacDonald, JS; Schwartz, MS; Smith, PF; Stubbs, RJ; Vyas, KP	1
Bradford, RH; Chremos, AN; Downton, M; Dujovne, C; Franklin, FA; Gould, AL; Hesney, M; Higgins, J; Hurley, DP; Shear, CL	1
De Liege, P; Gambert, P; Laurent, A; Lecoz, P; Legrand, A; Mikol, J; Peynet, J; Warnet, A	1
Curry, SC; Guidry, JR; Reust, CS	1
Gross, KF; London, SF; Ringel, SP	1
Burke, MT; Mantell, G; Staggers, J	1
England, JD; Stewart, PM; Viles, A; Walsh, JC	1
Gross, TP; Pierce, LR; Wysowski, DK	1
Frerman, FE; Greene, C; Walravens, PA	1
Illingworth, DR; Maher, VM; Pappu, A; Thompson, GR	1
Walker, JF	1
Hosenpud, J; Illingworth, DR; Munson, J; Norman, DJ	1

Reviews

9 review(s) available for lovastatin and Muscle Disorders

Article	Year
Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants. American heart journal, 2019, Volume: 210 Topics: Atorvastatin; Cardiovascular Diseases; Cause of Death; Chemical and Drug Induced Liver Injury; Double-Blind Method; Fluvastatin; Headache; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Lovastatin; Middle Aged; Muscular Diseases; Nausea; Neoplasms; Network Meta-Analysis; Placebos; Pravastatin; Randomized Controlled Trials as Topic; Risk Assessment; Rosuvastatin Calcium; Simvastatin; Withholding Treatment	2019
[Toxic myopathies related to the administration of hypolipidemic agents: are the drugs the only things responsible?]. Revista clinica espanola, 1995, Volume: 195, Issue:9 Topics: Adult; Aged; Bezafibrate; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Hypolipidemic Agents; Lovastatin; Male; Muscular Diseases; Simvastatin	1995
The role of cytochrome P450-mediated drug-drug interactions in determining the safety of statins. Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:7 Topics: Aged; Clinical Trials as Topic; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diltiazem; Drug Interactions; Enzyme Inhibitors; Female; Guidelines as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Isoenzymes; Itraconazole; Lovastatin; Male; Middle Aged; Muscular Diseases; Pravastatin; Rhabdomyolysis; Simvastatin	2001
Myopathy and rhabdomyolysis with lipid-lowering drugs. Toxicology letters, 2002, Mar-10, Volume: 128, Issue:1-3 Topics: Animals; Clofibrate; Female; Humans; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Muscular Diseases; Rhabdomyolysis	2002
Pharmacological interactions of statins. Atherosclerosis. Supplements, 2002, Volume: 3, Issue:1 Topics: Atorvastatin; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Tolerance; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Muscular Diseases; Pyrroles; Rhabdomyolysis	2002
Gemfibrozil-induced myopathy. Archives of internal medicine, 1991, Volume: 151, Issue:9 Topics: Clofibrate; Drug Therapy, Combination; Gemfibrozil; Humans; Hypertriglyceridemia; Lovastatin; Male; Middle Aged; Muscular Diseases	1991
Extended clinical safety profile of lovastatin. The American journal of cardiology, 1990, Sep-18, Volume: 66, Issue:8 Topics: Cataract; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Evaluation; Humans; Lovastatin; Multicenter Studies as Topic; Muscular Diseases	1990
Efficacy and long-term adverse effect pattern of lovastatin. The American journal of cardiology, 1988, Nov-11, Volume: 62, Issue:15 Topics: Alanine Transaminase; Clinical Trials as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver; Lovastatin; Muscular Diseases; Time Factors	1988
HMG CoA reductase inhibitors. Current clinical experience. Drugs, 1988, Volume: 36 Suppl 3 Topics: Eye Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Lovastatin; Muscular Diseases; Simvastatin	1988

Trials

9 trial(s) available for lovastatin and Muscle Disorders

Article	Year
Statin-associated myopathy with normal creatine kinase levels. Annals of internal medicine, 2002, Oct-01, Volume: 137, Issue:7 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Biopsy; Creatine Kinase; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Muscular Diseases; Pain; Pyrroles; Simvastatin	2002
Safety and compliance with once-daily niacin extended-release/lovastatin as initial therapy in the Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT) study. The American journal of cardiology, 2004, Aug-01, Volume: 94, Issue:3 Topics: Administration, Oral; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Hyperlipidemias; Liver Function Tests; Lovastatin; Male; Middle Aged; Muscular Diseases; Niacin; Patient Compliance; Probability; Prospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome	2004
Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up. The American journal of cardiology, 1994, Oct-01, Volume: 74, Issue:7 Topics: Alanine Transaminase; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Creatine Kinase; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Life Tables; Liver; Lovastatin; Male; Middle Aged; Muscular Diseases; Triglycerides; United States	1994
Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemia. Annals of internal medicine, 1993, Jun-01, Volume: 118, Issue:11 Topics: Aged; Cholesterol, HDL; Cholesterol, LDL; Creatine Kinase; Double-Blind Method; Estrogen Replacement Therapy; Female; Humans; Hypercholesterolemia; Lovastatin; Middle Aged; Muscular Diseases; Sex Factors; Transaminases	1993
Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin. The American journal of medicine, 1991, Jul-31, Volume: 91, Issue:1B Topics: Alanine Transaminase; Aspartate Aminotransferases; Combined Modality Therapy; Creatine Kinase; Dietary Fats; Double-Blind Method; Drug Eruptions; Female; Gastrointestinal Diseases; Humans; Hypercholesterolemia; Incidence; Lovastatin; Male; Middle Aged; Muscular Diseases; Nervous System Diseases	1991
Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia. Archives of internal medicine, 1991, Volume: 151, Issue:1 Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Creatine Kinase; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypercholesterolemia; Lipoproteins; Liver Function Tests; Lovastatin; Male; Middle Aged; Muscular Diseases; Patient Compliance; Triglycerides	1991
Lovastatin use and muscle damage in healthy volunteers undergoing eccentric muscle exercise. The Western journal of medicine, 1991, Volume: 154, Issue:2 Topics: Adult; Creatine Kinase; Double-Blind Method; Exercise; Humans; Lovastatin; Male; Muscles; Muscular Diseases	1991
Extended clinical safety profile of lovastatin. The American journal of cardiology, 1990, Sep-18, Volume: 66, Issue:8 Topics: Cataract; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Evaluation; Humans; Lovastatin; Multicenter Studies as Topic; Muscular Diseases	1990
Efficacy and long-term adverse effect pattern of lovastatin. The American journal of cardiology, 1988, Nov-11, Volume: 62, Issue:15 Topics: Alanine Transaminase; Clinical Trials as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver; Lovastatin; Muscular Diseases; Time Factors	1988

Other Studies

39 other study(ies) available for lovastatin and Muscle Disorders

Article	Year
Effect of SLCO1B1 T521C on Statin-Related Myotoxicity With Use of Lovastatin and Atorvastatin. Clinical pharmacology and therapeutics, 2021, Volume: 110, Issue:3 Topics: Aged; Aged, 80 and over; Aging; Atorvastatin; Case-Control Studies; Female; Genotype; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Lovastatin; Male; Muscular Diseases; Myotoxicity; Phenotype; Polymorphism, Single Nucleotide	2021
Clinical features related to statin-associated muscle symptoms. Muscle & nerve, 2019, Volume: 59, Issue:5 Topics: Aged; Atorvastatin; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Logistic Models; Lovastatin; Male; Medical History Taking; Middle Aged; Muscle Weakness; Muscular Diseases; Myalgia; Obesity; Odds Ratio; Pravastatin; Retrospective Studies; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Smoking; White People	2019
A pilot study on the association between Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2019, Volume: 24, Issue:7 Topics: Adult; Dyslipidemias; Female; Humans; Incidence; Liver-Specific Organic Anion Transporter 1; Lovastatin; Malaysia; Male; Middle Aged; Muscular Diseases; Pilot Projects; Polymorphism, Genetic; Prospective Studies; Risk Factors; Simvastatin	2019
Myotoxicity of lipid-lowering agents in a teenager with MELAS mutation. Pediatric neurology, 2008, Volume: 39, Issue:6 Topics: Adolescent; Anticholesteremic Agents; Creatine Kinase; DNA, Mitochondrial; Family Health; Female; Humans; Lovastatin; MELAS Syndrome; Muscle Weakness; Muscular Diseases; Mutation	2008
[Statin therapy and muscle disorders]. Orvosi hetilap, 2009, Feb-08, Volume: 150, Issue:6 Topics: Atorvastatin; Biological Availability; Cytochrome P-450 Enzyme System; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Half-Life; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Muscle, Skeletal; Muscular Diseases; Pravastatin; Pyrimidines; Pyrroles; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides	2009
Summaries for patients. Muscle abnormalities in four patients taking statins to treat unfavorable cholesterol levels. Annals of internal medicine, 2002, Oct-01, Volume: 137, Issue:7 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Biopsy; Creatine Kinase; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Muscular Diseases; Pain; Pyrroles; Simvastatin	2002
Side effects of statins--prevalence, relevance, consequences. Wiener klinische Wochenschrift, 2002, Nov-30, Volume: 114, Issue:21-22 Topics: Alanine Transaminase; Animals; Anticholesteremic Agents; Clinical Enzyme Tests; Clinical Trials as Topic; Cohort Studies; Erectile Dysfunction; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Liver; Lovastatin; Male; Muscular Diseases; Peripheral Nervous System Diseases; Pyridines; Risk Assessment; United States; United States Food and Drug Administration	2002
Three new drugs for hyperlipidemia. The Medical letter on drugs and therapeutics, 2003, Mar-03, Volume: 45, Issue:1151 Topics: Azetidines; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Ezetimibe; Humans; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Lovastatin; Muscular Diseases; Niacin	2003
Safety and statin therapy: reconsidering the risks and benefits. Archives of internal medicine, 2003, Mar-24, Volume: 163, Issue:6 Topics: Anticholesteremic Agents; Creatine Kinase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Lovastatin; Meta-Analysis as Topic; Muscular Diseases; Pravastatin; Pyridines; Randomized Controlled Trials as Topic; Retrospective Studies; Rhabdomyolysis; Transaminases; Treatment Outcome	2003
[Statin-induced Parkinson's-syndrome. Reader's letter on the article by J. Finsterer in "Der Nervenarzt" (2003) 74:115-122]. Der Nervenarzt, 2003, Volume: 74, Issue:8 Topics: Anticholesteremic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Muscular Diseases; Parkinsonian Disorders; Rhabdomyolysis	2003
Chinese red rice-induced myopathy. Southern medical journal, 2003, Volume: 96, Issue:12 Topics: Ascomycota; Biological Products; Creatine Kinase; Dietary Supplements; Humans; Lovastatin; Male; Middle Aged; Muscular Diseases	2003
Statin-associated exacerbation of myasthenia gravis. Neurology, 2004, Dec-14, Volume: 63, Issue:11 Topics: Atorvastatin; Cytokines; Dysarthria; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Lovastatin; Male; Middle Aged; Mitochondria; Models, Neurological; Muscular Diseases; Myasthenia Gravis; Neural Conduction; Pravastatin; Pyridostigmine Bromide; Pyrroles; Simvastatin; Th2 Cells; Ubiquinone	2004
Cerebrotendinous xanthomatosis: biochemical response to inhibition of cholesterol synthesis. British medical journal (Clinical research ed.), 1983, Jul-02, Volume: 287, Issue:6384 Topics: Adult; Anticholesteremic Agents; Brain Diseases, Metabolic; Humans; Lovastatin; Male; Muscular Diseases; Naphthalenes; Tendons; Xanthomatosis	1983
Lovastatin-induced myopathy in a hypothyroid patient. The Journal of family practice, 1995, Volume: 41, Issue:3 Topics: Female; Humans; Hypercholesterolemia; Hypothyroidism; Lovastatin; Middle Aged; Muscular Diseases	1995
HMG-CoA reductase inhibitors, gemfibrozil, and myopathy. The American journal of cardiology, 1995, Apr-15, Volume: 75, Issue:12 Topics: Drug Combinations; Drug Interactions; Follow-Up Studies; Gemfibrozil; Humans; Lovastatin; Muscular Diseases; Pravastatin	1995
Myxoedema revealed by simvastatin induced myopathy. BMJ (Clinical research ed.), 1994, Feb-26, Volume: 308, Issue:6928 Topics: Adult; Anticholesteremic Agents; Humans; Hypercholesterolemia; Lovastatin; Male; Muscular Diseases; Myxedema; Simvastatin	1994
Lovastatin and myopathy. The American journal of medicine, 1994, Volume: 96, Issue:3 Topics: Drug Synergism; Gemfibrozil; Humans; Lovastatin; Muscular Diseases; Pravastatin	1994
Biochemical diagnosis of myocardial infarction? Cardiac enzymes or caveat emptor. Postgraduate medical journal, 1994, Volume: 70, Issue:820 Topics: Creatine Kinase; Diagnosis, Differential; Humans; Lovastatin; Male; Middle Aged; Muscular Diseases; Myocardial Infarction; Simvastatin	1994
Effects of HMG-CoA reductase inhibitors on skeletal muscles of rabbits. Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1993, Volume: 193, Issue:5 Topics: Administration, Oral; Animals; Cholesterol; Creatine Kinase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; L-Lactate Dehydrogenase; Lovastatin; Male; Muscles; Muscular Diseases; Pravastatin; Rabbits; Simvastatin; Ubiquinone	1993
Experimental lovastatin myopathy. Journal of neuropathology and experimental neurology, 1993, Volume: 52, Issue:5 Topics: Acid Phosphatase; Animals; Basement Membrane; Female; Intracellular Membranes; Lovastatin; Microscopy, Electron; Mitochondria, Muscle; Muscles; Muscular Diseases; Organelles; Rats; Rats, Inbred Lew	1993
Gemfibrozil-lovastatin-associated myalgia. The American journal of cardiology, 1993, Feb-15, Volume: 71, Issue:5 Topics: Drug Therapy, Combination; Gemfibrozil; Humans; Lovastatin; Muscular Diseases	1993
Enhanced myopathy following administration of hypolipidemic agents under urethane anesthesia. Biological & pharmaceutical bulletin, 1997, Volume: 20, Issue:1 Topics: Anesthesia; Animals; Bezafibrate; Calcium; Creatine Kinase; Hypolipidemic Agents; Lovastatin; Male; Muscular Diseases; Pravastatin; Rats; Rats, Wistar; Simvastatin; Urethane	1997
Rhabdomyolysis associated with simvastatin-gemfibrozil therapy. Southern medical journal, 1997, Volume: 90, Issue:5 Topics: Anticholesteremic Agents; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lovastatin; Middle Aged; Muscular Diseases; Rhabdomyolysis; Simvastatin	1997
Simvastatin-induced myopathy in a patient treated for hypercholesterolemia. Morphological aspects. Polish journal of pathology : official journal of the Polish Society of Pathologists, 1997, Volume: 48, Issue:1 Topics: Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Muscle, Skeletal; Muscular Diseases; Simvastatin	1997
Increased lipid peroxidation in a patient with CK-elevation and muscle pain during statin therapy. Atherosclerosis, 2000, Volume: 153, Issue:1 Topics: Creatine Kinase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipid Peroxides; Lovastatin; Male; Middle Aged; Muscular Diseases; Pain	2000
Statin induced myopathy does not show up in MIBI scintigraphy. Nuclear medicine communications, 2001, Volume: 22, Issue:5 Topics: Adult; Anticholesteremic Agents; Atorvastatin; Breast Neoplasms; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Indoles; Lovastatin; Male; Middle Aged; Muscle, Skeletal; Muscular Diseases; Pain; Pravastatin; Pyridines; Pyrroles; Radionuclide Imaging; Radiopharmaceuticals; Simvastatin; Technetium Tc 99m Sestamibi	2001
Experimental simvastatin-induced myopathy in rabbits. Journal of the neurological sciences, 1992, Volume: 113, Issue:1 Topics: Administration, Oral; Animals; Electromyography; Enzymes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lovastatin; Male; Muscles; Muscular Diseases; Rabbits; Simvastatin	1992
Lovastatin/gemfibrozil myopathy: a clinical, histochemical, and ultrastructural study. European neurology, 1992, Volume: 32, Issue:5 Topics: Drug Therapy, Combination; Female; Gemfibrozil; Humans; Lovastatin; Microscopy, Electron; Middle Aged; Muscles; Muscular Diseases	1992
Myopathy associated with HMG-CoA reductase inhibitors (HMGRIs) and cyclosporin A: evaluation in a rat model. European heart journal, 1992, Volume: 13 Suppl B Topics: Animals; Anticholesteremic Agents; Cyclosporine; Drug Synergism; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Muscles; Muscular Diseases; Necrosis; Pravastatin; Rats; Rats, Inbred Strains; Simvastatin; Structure-Activity Relationship	1992
Pravastatin and simvastatin for hypercholesterolemia. The Medical letter on drugs and therapeutics, 1991, Mar-08, Volume: 33, Issue:839 Topics: Anticholesteremic Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Heptanoic Acids; Humans; Hypercholesterolemia; Lovastatin; Muscular Diseases; Naphthalenes; Pravastatin; Simvastatin	1991
HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies. The Journal of pharmacology and experimental therapeutics, 1991, Volume: 257, Issue:3 Topics: Animals; Biliary Tract; Cholestasis; Cyclosporins; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Lovastatin; Male; Microsomes, Liver; Muscular Diseases; Naphthalenes; Pravastatin; Rats; Rats, Inbred Strains; Simvastatin	1991
Cerebrotendinous xanthomatosis: treatments with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblings. Neurology, 1991, Volume: 41, Issue:3 Topics: Adult; Anticholesteremic Agents; Brain Diseases; Chenodeoxycholic Acid; Female; Humans; Lovastatin; Muscular Diseases; Simvastatin; Tendons; Tomography, X-Ray Computed; Xanthomatosis	1991
Cholesterol-lowering agent myopathy (CLAM). Neurology, 1991, Volume: 41, Issue:7 Topics: Aged; Anticholesteremic Agents; Female; Gemfibrozil; Humans; Lovastatin; Muscular Diseases	1991
Muscle side effects associated with simvastatin therapy. The Medical journal of Australia, 1990, Nov-05, Volume: 153, Issue:9 Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Child; Female; Humans; Lovastatin; Male; Middle Aged; Mitochondria, Muscle; Muscular Diseases; Pain; Simvastatin	1990
Myopathy and rhabdomyolysis with lovastatin taken with gemfibrozil. JAMA, 1990, Dec-19, Volume: 264, Issue:23 Topics: Adolescent; Creatine Kinase; Drug Synergism; Drug Therapy, Combination; Gemfibrozil; Humans; Isoenzymes; Lovastatin; Male; Middle Aged; Muscular Diseases; Rhabdomyolysis	1990
Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. JAMA, 1990, Jul-04, Volume: 264, Issue:1 Topics: Acute Kidney Injury; Adult; Aged; Creatine Kinase; Drug Interactions; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Muscular Diseases; Rhabdomyolysis	1990
Lovastatin, isoprenes, and myopathy. Lancet (London, England), 1989, Nov-04, Volume: 2, Issue:8671 Topics: Creatine Kinase; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Muscular Diseases; Ubiquinone	1989
Plasma mevalonate response in lovastatin-related myopathy. Lancet (London, England), 1989, Nov-04, Volume: 2, Issue:8671 Topics: Aged; Creatine Kinase; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Mevalonic Acid; Middle Aged; Muscular Diseases	1989
Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin. The New England journal of medicine, 1988, Jan-07, Volume: 318, Issue:1 Topics: Acute Kidney Injury; Heart Transplantation; Humans; Lovastatin; Male; Middle Aged; Muscular Diseases; Postoperative Complications	1988